| Line item | 2026-03-31 FY | 2025-03-31 FY | 2024-03-31 FY | 2023-03-31 FY | 2022-03-31 FY | 2021-03-31 FY |
|---|---|---|---|---|---|---|
| Revenue | – | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – | – |
| Gross Profit | – | – | – | – | – | – |
| Operating Expenses | $532.90M | $438.15M | $282.71M | $218.28M | $156.03M | $108.12M |
| R&D | $456.66M | $360.92M | $212.93M | $160.26M | $101.81M | $68.60M |
| SG&A | $76.24M | $77.23M | $57.28M | $48.02M | $54.23M | $39.51M |
| Operating Income | – | – | – | – | – | – |
| Interest Expense | – | – | – | – | – | $0.00 |
| Tax Expense | $215.00K | $891.00K | $567.00K | $9.00K | -$84.00K | -$358.00K |
| Net Income | -$505.61M | -$413.84M | -$259.34M | -$210.96M | -$156.73M | -$107.43M |
| EPS (basic) | -2.7700 | -2.7300 | -1.8800 | -1.7100 | -1.4300 | -1.2200 |
| EPS (diluted) | -2.7700 | -2.7300 | -1.8800 | -1.7100 | -1.4300 | -1.2200 |
| Shares (diluted) | $182.42M | $151.57M | $138.10M | $123.08M | $109.68M | $87.76M |